We're not another national quick-fix company
Another meta-analysis, which looked at relevant data from multiple clinical studies, estimated that 40-70% of people on GLP-1 drugs will experience nausea at some point while taking the medication
The practical bottom line: if you need a weight loss medication today, tirzepatide is the proven, available option with years of safety data
however, these results should be considered preliminary while awaiting longer term follow-up and mechanistic-based studies
GLP-3 is informal shorthand used in catalogs and some literature for triple agonists of the GLP-1, GIP, and glucagon receptors
With 24hrdoc, this lower-dose approach is offered through licensed providers who focus on safety, oversight, and long-term metabolic support rather than aggressive dosing